Analysis

Walmart (WMT) is gearing up to report Q3 results. Here’s what to expect

Walmart Inc. (NYSE: WMT) has consistently delivered stable performance across various market conditions, with the company's focus on grocery and other consumer

What to expect when Target (TGT) reports its Q3 2024 earnings results

Shares of Target Corporation (NYSE: TGT) stayed green on Thursday. The stock has gained 9% over the past three months. The retailer

A few points of note on Home Depot’s (NYSE: HD) 3Q24 performance

Shares of Home Depot (NYSE: HD) were up over 1% on Wednesday. The stock has gained 15% over the past three months.

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Alibaba Group (BABA) Q2 2025 Earnings: Key financials and quarterly highlights

Alibaba Group Holding Limited (NYSE: BABA) reported its second quarter 2025 earnings results today. Revenue was $33.7 billion, up 5% year-over-year. Net income attributable to ordinary shareholders grew 58% to

November 15, 2024

AMAT Earnings: Applied Materials Q4 revenue and profit increase YoY

Applied Materials, Inc. (NASDAQ: AMAT) announced financial results for the fourth quarter of 2024, reporting an increase in revenue and adjusted earnings. Adjusted earnings of the semiconductor technology company increased

November 14, 2024

What to expect when Target (TGT) reports its Q3 2024 earnings results

Shares of Target Corporation (NYSE: TGT) stayed green on Thursday. The stock has gained 9% over the past three months. The retailer is scheduled to report its earnings results for

November 14, 2024

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top